We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ahmet Hoke MD, PhD

Ahmet Hoke MD, PhD

Professor of Neurology and Neuroscience; Director, Neuromuscular Division; Director, Neuromuscular Medicine Fellowship, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland

Dr. Ahmet Hoke received his medical degree from Hacettepe University in Ankara, Turkey. He then completed an internship and residency in medicine at MetroHealth Saint Luke’s Medical Center in Cleveland, OH. He completed his Ph.D. in Neuroscience at Case Western Reserve University before joining The Johns Hopkins for his neurology residency. He went on to the University of Calgary for a neuromuscular fellowship.

Now Professor of Neurology and Neuroscience and Director of the Daniel B. Drachman Division of Neuromuscular Diseases at Johns Hopkins, Dr. Hoke focuses on neuromuscular diseases with a particular interest in peripheral nerve diseases. He has specialized expertise in nerve conduction studies, electromyography and nerve and muscle biopsy reading. In 2005, he received the coveted Derek Denny Brown Young Neurological Scholar Award given by the American Neurological Association to a member of the association who has achieved a significant stature in neurological research and whose promise of continuing major contributions to the field of neurology is anticipated.

Dr. Hoke’s research interest includes studies on biology of peripheral axons and Schwann cells and disorders affecting the peripheral nervous system. He uses in vitro and in vivo models of peripheral neuropathies (HIV-associated sensory neuropathy, diabetic neuropathy and toxic neuropathies) to study the mechanism of axonal damage and develop therapeutic targets for drug development. In addition, he has an additional research interest focusing on mechanisms of axonal degeneration and regeneration using in vitro and in vivo models. He researches novel chemicals to treat peripheral neuropathies and utilizes engineered stem cells as therapeutic gene delivery tools to promote axonal regeneration in chronically denervated nerves as seen in nerve injuries and many degenerating disorders of the peripheral nervous system such as amyotrophic lateral sclerosis and inherited neuropathies.

Dr. Hoke currently sees patients at The Johns Hopkins Outpatient Center located in Baltimore on Tuesdays and Wednesdays.


  •         American Board of Psychiatry and Neurology

Fellow of the Royal College of Physicians and Surgeons of Canada

Recent Contributions to PracticeUpdate:

  1. Oral Fluoroquinolone and Risk for Peripheral Neuropathy